Pharma News

This section covers the managerial aspects in the Pharma industry.

Mallinckrodt to Sell Intrathecal Therapy Business to Piramal Enterprises Limited

Tuesday, January 31, 2017

Mallinckrodt plc a leading specialty pharmaceutical company announced it has entered into an agreement under which it will sell its Intrathecal Therapy business to Piramal Enterprises Limited39s subsidiary in the UK Piramal Critical Care for approximately 203 million including fixed and contingent c..

Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement

Tuesday, January 31, 2017

Ferring Pharmaceuticals and Enteris BioPharma Inc announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris39 proprietary and patented oral peptide and small molecule delivery platform Peptelligence to engineer an oral formula..

Endo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP

Tuesday, January 31, 2017

Endo International plc announced that one of its operating companies Par Pharmaceutical has received final approval from the US Food and Drug Administration for its New Drug Application for ephedrine sulfate injection a drug administered parenterally as a pressor agent to address clinically importan..

Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial

Monday, January 30, 2017

Astellas Pharma Inc and Ironwood Pharmaceuticals Inc announced topline results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation CC met its primary endpoint Linaclotide is approved in Japan as the first prescription treatment for adul..

Mallinckrodt Completes Sale of its Nuclear Imaging Business to IBA Molecular for $690 million

Monday, January 30, 2017

Mallinckrodt plc a leading specialty pharmaceutical company announced that it has closed the sale of its global Nuclear Imaging business to IBA Molecular IBAM for approximately 690 million before tax including upfront and contingent considerations and the assumption of longterm obligations Mallinckr..

Vicore Pharma is granted orphan drug designation from FDA for the treatment of IPF

Saturday, January 28, 2017

FDA has granted orphan drug designation for Vicore Pharma39s drug candidates C21 for the treatment of IPF C21 is thereby approved as an orphan drug in the USA The approval brings C21 exclusivity on the US market from when the drug will be approved and for 7 years thereafter Other benefits related to..

Celgene to Acquire Delinia, Inc.

Friday, January 27, 2017

Celgene Corporation and Delinia Inc a privately held biotechnology company developing novel therapeutics for autoimmune diseases today announced that they have entered into an agreement for the acquisition of Delinia by Celgene The transaction expands Celgenes Inflammation and Immunology pipeline t..

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon

Friday, January 27, 2017

Medtronic plc MDT announced receipt of an investigational device exemption IDE from the US Food and Drug Administration FDA to initiate a study of the INPACT Admiral drugcoated balloon DCB for a potential new indication in patients with endstage renal disease The randomized study will evaluate the I..

CrownBio Announces Expansion of Life Science Division

Friday, January 27, 2017

Crown Bioscience a whollyowned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research announced its intention to significantly increase focus on the Life Science di..

European Commission Grants Orphan Drug Designation to Cabiralizumab (FPA008)

Wednesday, January 25, 2017

Five Prime Therapeutics Inc announced that the European Commission has granted orphan designation for cabiralizumab FPA008 for the treatment of tenosynovial giant cell tumour localised and diffuse type also known as Pigmented Villonodular Synovitis PVNS a locally aggressive tumor of the synovium PV..

Biocon Ltd Wins MYR 300 Million Contract for Insulin from MoH, Malaysia

Wednesday, January 25, 2017

Biocon Ltd Asia39s premier biopharmaceuticals company announced today that the Ministry of Health MoH Malaysia has awarded a three year contract to its subsidiary Biocon SDN BHD Malaysia for supplying recombinant human insulin rhInsulin formulations manufactured at its large scale biopharmaceutical ..

Evotec Enters into an Integrated Drug Discovery Collaboration with Asahi Kasei Pharma (Japan)

Friday, January 20, 2017

Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation a wholly owned subsidiary of Asahi Kasei Corporation Tokyo Japan Under the terms of the agreement Evotec will apply its integrated drug discovery platform ..

Ethypharm Acquires Martindale Pharma in the UK

Friday, January 20, 2017

Ethypharm is pleased to announce today that it has signed a definitive agreement to acquire Martindale Pharma Martindale Pharma is a leading UKbased specialty pharmaceutical company providing essential medicines to over 50 countries around the world The company specializes in the field of opioid a..

Symbiomix Therapeutics Submits New Drug Application to US FDA for Solosec™

Friday, January 20, 2017

Symbiomix a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections today announced submission of a new drug application NDA for Solosec secnidazole oral granules for the treatment of bacterial vaginosis BV to the US Food and Drug Administration FDA S..

Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid

Thursday, January 19, 2017

Eli Lilly and Company and CoLucid Pharmaceuticals Inc announced an agreement for Lilly to acquire CoLucid for 4650 per share or approximately 960 million This allcash transaction will enhance Lilly39s existing portfolio in pain management for migraine while adding a potential nearterm launch to its ..

Takeda and Ovid Therapeutics Announce Clinical Development and Commercialization Collaboration for TAK-935

Thursday, January 19, 2017

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc a privatelyheld biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases today announced the formation of a global collaboration focused on the clinical development a..

Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics

Wednesday, January 18, 2017

Evotec AG and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP a Torontobased company focused on developing firstinclass therapeutics targeting fibrotic diseases The company was launched with CDN 28 m approx 21 m financing which includes cash from MaRS Innovation Evotec will ..

Progenra Discovers Novel Immune Oncology Drug

Wednesday, January 18, 2017

Progenra Inc announced a new immuneoncology drug whose mechanism differs from available cancer immunotherapies Opdivo and Keytruda The findings published by Progenra with Dr Wayne Hancock University of Pennsylvania School of Medicine support a new immuneoncology antitumor strategy by inhibiting USP7..

MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain

Wednesday, January 18, 2017

MilliporeSigma a leading science and technology company today announced the opening of a facility in Mollet des Valls Spain dedicated to the manufacture of meglumine an FDAapproved excipient for pharmaceuticals and a component of medical imaging contrast media The facility validated by the FDA is t..

Benitec Biopharma Receives Orphan Drug Designation in the European Union for BB-301

Tuesday, January 17, 2017

Benitec Biopharma Limited is pleased to announce that the European Commission based on a favourable recommendation from the European Medicines Agency EMA Committee for Orphan Medicinal Products COMP has granted Orphan Drug Designation to BB301 as an orphan medicinal product for the treatment of pati..

TOP